Brian Udell, MD - Low Dose Naltrexone - Key Ingredient in the Biomedical Treatment of Autism Spectrum Disorder (2019 Conference) (LDN, low dose naltrexone)


Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

Session Outline: Background - describes ASD and Epidemic Proportions. Treatment - Traditional therapies, Medical therapies, Biomedical therapies. LDN protocols.resentation Dr Livengood discusses how to treat depression in patients with autoimmune diseases.  Dr Livengood shares case studies of patients who suffer from depression and autoimmune disease, treating the patient holistically helped so much more than treating the individual illness. Recognising that there is much more going on with a patient than just the main symptom described.